Acorah Software Products - Accounts Production 16.0.110 false true 31 January 2023 1 February 2022 false true No description of principal activity 1 February 2023 31 January 2024 31 January 2024 11750438 Dr William Sharp iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11750438 2023-01-31 11750438 2024-01-31 11750438 2023-02-01 2024-01-31 11750438 frs-core:CurrentFinancialInstruments 2024-01-31 11750438 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 11750438 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 11750438 frs-bus:Micro-entities 2023-02-01 2024-01-31 11750438 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 11750438 frs-bus:Director1 2023-02-01 2024-01-31 11750438 2022-01-31 11750438 2023-01-31 11750438 2022-02-01 2023-01-31 11750438 frs-core:CurrentFinancialInstruments 2023-01-31
Registered number: 11750438
Sharp Medical Solutions Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2024
Balance Sheet
Registered number: 11750438
2024 2023
£ £
Fixed assets 1,548 1,548
Current assets 3,914 4,557
Creditors: Amounts Falling Due Within One Year (3,598 ) (4,241 )
NET CURRENT ASSETS 316 316
TOTAL ASSETS LESS CURRENT LIABILITIES 1,864 1,864
NET ASSETS 1,864 1,864
CAPITAL AND RESERVES 1,864 1,864

Notes

1. General Information
Sharp Medical Solutions Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11750438 . The registered office is 52 Portland Road, Hove, BN3 5DL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
Page 0
Page 1
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr William Sharp
Director
23rd October 2024